Galena Settles Kickback Allegations for $7.5 Million

Drug Industry Daily
A A
Galena Biopharma agreed to pay more than $7.5 million to settle a whistleblower suit alleging the drugmaker violated the False Claims Act by paying doctors to prescribe its fentanyl-based drug Abstral.

To View This Article:

Login

Subscribe To Drug Industry Daily